Outcome after autologous hemopoietic stem cell transplantation in relapsed or refractory childhood Hodgkin disease

Journal of Pediatric Hematology/Oncology

Volumn 26, Issue 11, 2004, Pages 740-745

  Stoneham, Sara ^a   Ashley, Sue ^b   Pinkerton, C Ross ^b   Wallace, W Hamish ^c   Shankar, Ananth Gouri ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Childhood; Hodgkin disease; Refractory; Relapse; Stem cell transplantation; Survival

Indexed keywords

BLEOMYCIN; CARMUSTINE; CHLORAMBUCIL; CISPLATIN; CYTARABINE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; PREDNISOLONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH HAZARD; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SALVAGE THERAPY; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, NEOPLASM; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; MALE; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 9644276872     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200411000-00010     Document Type: Review

References (29)

1. Thompson AB, Wallace WH. Treatment of paediatric Hodgkin's disease: a balance of risks. Eur J Cancer. 2002;38:468-477.
2. Vecchi V, Pileri S, Burnelli R, et al. Treatment of paediatric Hodgkin's disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicentre study on 215 patients. Cancer. 1993;72:2049-2057.
3. Maity A, Goldwein JW, Lange B, et al. Comparison of high dose and low dose radiation with and without chemotherapy for children with Hodgkin's disease: an analysis of the experience at the Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania. J Clin Oncol. 1992;10:929-935.
4. Weiner MA, Leventhal B, Brecher ML, et al. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients. A Pediatric Oncology Group study. J Clin Oncol. 1997;15:2769-2779.
5. Oberlin O, Leverger G, Pacquement H, et al. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology. J Clin Oncol. 1992;10:1602-1608.
6. Hurd DD, Haake RJ, Lasky LC. et al. Treatment of refractory and relapsed Hodgkin's disease: intensive chemotherapy and autologous bone marrow or peripheral blood stem cell support. Med Pediatr Oncol. 1990;18:447-453.
7. Horning SJ, Negrin RS, Chao JC, et al. Fractionated total body irradiation, etoposide and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma. J Clin Oncol. 1994;12:2552-2558.
8. Horning SJ, Chao NJ, Negrin RS, et al. High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices. Blood. 1997;89:801-813.
9. Nademanee A, Sniecinski I, Schmidt GM, et al. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. J Clin Oncol. 1994;12:2176-2186.
10. Weaver CH, Schwartzberg L, Li W, et al. High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease. Bone Marrow Transplant. 1996;17:715-721.
11. Reece DE, Phillips GL. Intensive therapy and autologous stem cell transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Leuk Lymphoma. 1996;21:245-253.
12. Nademanee A, O'Donnell MR, Snyder DS, et al. High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors. Blood. 1995;85:1381-1390.
13. Kessinger A, Vose JM, Bierman PJ, et al. High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging. Exp Hematol. 1991;19:1013-1016.
14. Bierman PJ, Bagin RG, Jagannath S, et al. High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients. Ann Oncol. 1993;4:767-773.
15. Bierman PJ, Anderson JR, Freeman MB, et al. High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy. Ann Oncol. 1996;7:151-156.
16. Yuen AR, Rosenberg SA, Hoppe RT, et al. Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. Blood. 1997;89:814-822.
17. Shankar AG, Ashley S, Radford M, et al. Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group. J Clin Oncol. 1997;15:2622-2630.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
19. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 1977;35:1-39.
20. Cox DR. Regression models and life tables. J Roy Stat Soc B. 1972;24:187-202.
21. Baker KS, Gordon BG, Gross TG, et al. Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents. J Clin Oncol. 1999;17:825-831.
22. Balwierz W, Moryl-Bujakowska A, Boguslawska-Jaworska J, et al. The incidence and treatment of the first relapse in children with Hodgkin's disease. Med Wieku Rozwoj. 2000;4:73-84.
23. Bessa E, Pacquement H, Hartmann O, et al. Long term survival of refractory or relapsed Hodgkin's disease treated by high dose chemotherapy with haemopoietic support. Med Pediatr Oncol. 1993;21:84.
24. Williams CD, Goldstone AH, Pearce R, et al. Autologous bone marrow transplantation for pediatric Hodgkin's disease: a case-matched comparison with adult patients by the European Bone Marrow Transplant Group Lymphoma Registry. J Clin Oncol. 1993;11:2243-2249.
25. Shankar AG, Ashley S, Atra A, et al. A limited role for VEEP (vincristine, etoposide, epirubicin, prednisolone) chemotherapy in childhood Hodgkin's disease. Eur J Cancer. 1998;34:2058-2063.
26. Barrett A, Crennan E, Barnes J, et al. Treatment of clinical stage 1 Hodgkin's disease by local radiation therapy alone. A United Kingdom Children's Cancer Study Group study. Cancer. 1990;66:670-674.
27. Bonadonna G, Santoro A, Gianni AM, et al. Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience. Ann Oncol 1991;2(Suppl 1):9-16.
28. Longo DL, Duffey PL, Young RC, et al. Conventional dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. J Clin Oncol. 1992;10:210-218.
29. Lazarus HM, Rowlings PA, Zhang MJ, et al. Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol. 1999;17:534-545.